Core Viewpoint - On October 16, Jiuan Medical experienced a 1.29% increase in stock price with a trading volume of 537 million yuan, indicating strong market interest and activity in the company's shares [1]. Financing Summary - On October 16, Jiuan Medical had a financing purchase amount of 63.86 million yuan and a financing repayment of 55.10 million yuan, resulting in a net financing purchase of 8.76 million yuan. The total financing and securities balance reached 1.21 billion yuan [1]. - The current financing balance of 1.20 billion yuan accounts for 6.34% of the circulating market value, which is above the 80th percentile level over the past year, indicating a high level of financing activity [1]. - In terms of securities lending, Jiuan Medical repaid 2,000 shares and sold 5,000 shares on October 16, with a selling amount of 203,900 yuan. The remaining securities lending volume is 244,300 shares, with a balance of 9.96 million yuan, also exceeding the 90th percentile level over the past year [1]. Business Performance - As of September 19, Jiuan Medical had 72,000 shareholders, a decrease of 1.50% from the previous period, while the average circulating shares per person increased by 1.53% to 6,582 shares [2]. - For the first half of 2025, Jiuan Medical reported a revenue of 765 million yuan, a year-on-year decrease of 43.35%, while the net profit attributable to the parent company was 920 million yuan, reflecting a year-on-year increase of 52.91% [2]. Dividend and Shareholding Structure - Since its A-share listing, Jiuan Medical has distributed a total of 1.794 billion yuan in dividends, with 1.39 billion yuan distributed over the past three years [3]. - As of June 30, 2025, among the top ten circulating shareholders, Huabao Zhongzheng Medical ETF held 10.99 million shares, a decrease of 1.836 million shares from the previous period. The Southern Zhongzheng 500 ETF held 4.936 million shares, down by 128,100 shares. Hong Kong Central Clearing Limited entered the top ten shareholders with 2.7895 million shares [3].
九安医疗10月16日获融资买入6385.63万元,融资余额12.01亿元